Unraveling the Dietary Puzzle: Exploring the Influence of Diet, Nutraceuticals, and Supplements on Bladder Cancer Risk, Outcomes, and Immunotherapy Efficacy: Insights from the BLOSSOM Study and Beyond.

Autor: Buonerba C; Oncology Unit, 'Andrea Tortora' Hospital, ASL Salerno, Presidio Ospedaliero A.Tortora, Via Alcide de Gasperi, 59, 84016, Pagani, SA, Italy.; Associazione O.R.A. ETS-Oncology Research Assistance, Somma Vesuviana, Italy.; Department of Public Health, 'Federico II' University, 80131, Naples, Italy., Ingenito C; Oncology Unit, 'Andrea Tortora' Hospital, ASL Salerno, Presidio Ospedaliero A.Tortora, Via Alcide de Gasperi, 59, 84016, Pagani, SA, Italy., Di Trolio R; Unit of Melanoma, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori Istituto di Ricovero e Cura a Carattere Scientifico Fondazione G. Pascale, Naples, Italy., Cappuccio F; Oncology Unit, 'Andrea Tortora' Hospital, ASL Salerno, Presidio Ospedaliero A.Tortora, Via Alcide de Gasperi, 59, 84016, Pagani, SA, Italy., Rubino R; Oncology Unit, 'Andrea Tortora' Hospital, ASL Salerno, Presidio Ospedaliero A.Tortora, Via Alcide de Gasperi, 59, 84016, Pagani, SA, Italy., Piscosquito A; Oncology Unit, 'Andrea Tortora' Hospital, ASL Salerno, Presidio Ospedaliero A.Tortora, Via Alcide de Gasperi, 59, 84016, Pagani, SA, Italy., Verde A; Oncology Unit, 'Andrea Tortora' Hospital, ASL Salerno, Presidio Ospedaliero A.Tortora, Via Alcide de Gasperi, 59, 84016, Pagani, SA, Italy.; Associazione O.R.A. ETS-Oncology Research Assistance, Somma Vesuviana, Italy., Costabile F; Oncology Unit, 'Andrea Tortora' Hospital, ASL Salerno, Presidio Ospedaliero A.Tortora, Via Alcide de Gasperi, 59, 84016, Pagani, SA, Italy.; Associazione O.R.A. ETS-Oncology Research Assistance, Somma Vesuviana, Italy., Iuliucci M; Oncology Unit, 'Andrea Tortora' Hospital, ASL Salerno, Presidio Ospedaliero A.Tortora, Via Alcide de Gasperi, 59, 84016, Pagani, SA, Italy., Crocetto F; Department of Neurosciences, Reproductive and Odontostomatological Sciences, Urology and Andrology Unit, University of Naples Federico II, Via Pansini No. 5, 80131, Naples, Italy., Chiancone F; Department of Urology, AORN A. Cardarelli, Naples, Italy., Nacchia A; Urology Unit, Ospedale Sant'Andrea, 'Sapienza' University of Rome, 00191, Rome, Italy., Campitelli A; Department of Urology, Umberto I, Nocera Inferiore, Salerno, Italy., Scafuri L; Oncology Unit, 'Andrea Tortora' Hospital, ASL Salerno, Presidio Ospedaliero A.Tortora, Via Alcide de Gasperi, 59, 84016, Pagani, SA, Italy.; Associazione O.R.A. ETS-Oncology Research Assistance, Somma Vesuviana, Italy., Sanseverino R; Department of Urology, Umberto I, Nocera Inferiore, Salerno, Italy., Di Lorenzo G; Oncology Unit, 'Andrea Tortora' Hospital, ASL Salerno, Presidio Ospedaliero A.Tortora, Via Alcide de Gasperi, 59, 84016, Pagani, SA, Italy. direttoreuocpagani@gmail.com.; Associazione O.R.A. ETS-Oncology Research Assistance, Somma Vesuviana, Italy. direttoreuocpagani@gmail.com.; Department of Medicine and Health Sciences 'Vincenzo Tiberio', University of Molise, Campobasso, Italy. direttoreuocpagani@gmail.com.

Publikováno v: Oncology and therapy [Oncol Ther] 2024 Jun; Vol. 12 (2), pp. 189-195. Date of Electronic Publication: 2024 Feb 28.

Synergistic Combination of Quercetin and Mafosfamide in Treatment of Bladder Cancer Cells.

Autor: Spagnuolo C; National Research Council, Institute of Food Sciences, 83100 Avellino, Italy., Mautone F; National Research Council, Institute of Food Sciences, 83100 Avellino, Italy., Meola AMI; National Research Council, Institute of Food Sciences, 83100 Avellino, Italy., Moccia S; National Research Council, Institute of Food Sciences, 83100 Avellino, Italy., Di Lorenzo G; Oncology Unit, Hospital 'Andrea Tortora', ASL Salerno, 84016 Pagani, Italy., Buonerba C; Associazione O.R.A. ETS, Oncology Research Assistance, 84134 Salerno, Italy., Russo GL; National Research Council, Institute of Food Sciences, 83100 Avellino, Italy.

Publikováno v: Molecules (Basel, Switzerland) [Molecules] 2024 Oct 31; Vol. 29 (21). Date of Electronic Publication: 2024 Oct 31.

Exploring a Novel Approach to Spare Classic Chemotherapy in HER2-Low, ER-Positive Breast Cancer Based on Trastuzumab Deruxtecan Combined with Endocrine Therapy.

Autor: Scafuri L; Oncology Unit, 'Andrea Tortora' Hospital, ASL Salerno, Pagani, Italy. lucaluca@hotmail.it.; Associazione O.R.A. ETS-Oncology Research Assistance, Salerno, Italy. lucaluca@hotmail.it., Buonerba C; Oncology Unit, 'Andrea Tortora' Hospital, ASL Salerno, Pagani, Italy.; Associazione O.R.A. ETS-Oncology Research Assistance, Salerno, Italy., Di Lauro V; Department of Breast & Thoracic Oncology, Division of Breast Medical Oncology, Istituto Nazionale Tumori IRCCS 'Fondazione G. Pascale', Naples, Italy., Tortora V; S.C. Oncologia, ASL Vercelli, Vercelli, Italy., Cascella M; Anesthesia and Pain Medicine, Department of Medicine, Surgery and Dentistry 'Scuola Medica Salernitana', University of Salerno, Via S. Allende, 84081, Baronissi, Italy., Liguori L; Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy., Sciarra A; Department of Experimental Medicine, University of Campania 'Luigi Vanvitelli', Naples, NA, Italy., Sabbatino F; Oncology Unit, Department of Medicine, Surgery and Dentistry, University of Salerno, 84081, Baronissi, Salerno, Italy., Diana A; Medical Oncology Unit, Ospedale del Mare, Naples, Italy., Marra A; European Institute of Oncology-IRCCS, Milan, Italy., Tarantino P; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy., Trapani D; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Division of Early Drug Development for Innovative Therapy, European Institute of Oncology-IRCCS, Milan, Italy., Giuliano M; Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy., Arpino G; Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy., Curigliano G; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Division of Early Drug Development for Innovative Therapy, European Institute of Oncology-IRCCS, Milan, Italy., Di Lorenzo G; Oncology Unit, 'Andrea Tortora' Hospital, ASL Salerno, Pagani, Italy.; Associazione O.R.A. ETS-Oncology Research Assistance, Salerno, Italy.

Publikováno v: Oncology and therapy [Oncol Ther] 2024 Sep; Vol. 12 (3), pp. 363-373. Date of Electronic Publication: 2024 Jun 28.

Gender minorities in breast cancer - Clinical trials enrollment disparities: Focus on male, transgender and gender diverse patients.

Autor: Miglietta F; Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy; Oncology 2 Unit, Istituto Oncologico Veneto - IOV IRCCS, Padova, Italy., Pontolillo L; UOC Oncologia Medica, Comprehensive Cancer Center, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy; Medical Oncology, Department of Traslational Medicine and Surgery, Università Cattolica del Sacro Cuore, Rome, Italy., De Angelis C; Department of Clinical Medicine and Surgery, University Federico II, Naples, Italy., Caputo R; Department of Breast and Thoracic Oncology, Division of Breast Medical Oncology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Pascale, Naples, Italy., Marino M; Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy; Oncology 2 Unit, Istituto Oncologico Veneto - IOV IRCCS, Padova, Italy., Bria E; Medical Oncology, Department of Traslational Medicine and Surgery, Università Cattolica del Sacro Cuore, Rome, Italy; UOSD Oncologia Toraco-Polmonare, Comprehensive Cancer Center, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy., Di Rienzo R; Department of Clinical Medicine and Surgery, University Federico II, Naples, Italy., Verrazzo A; Department of Breast and Thoracic Oncology, Division of Breast Medical Oncology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Pascale, Naples, Italy., Buonerba C; Oncology Unit, Hospital 'Andrea Tortora', ASL Salerno, Pagani, Italy; Associazione O.R.A. ETS - Oncology Research Assistance, Salerno, Italy., Tortora G; UOC Oncologia Medica, Comprehensive Cancer Center, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy; Medical Oncology, Department of Traslational Medicine and Surgery, Università Cattolica del Sacro Cuore, Rome, Italy., Di Lorenzo G; Oncology Unit, Hospital 'Andrea Tortora', ASL Salerno, Pagani, Italy; Associazione O.R.A. ETS - Oncology Research Assistance, Salerno, Italy., Del Mastro L; UO Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genoa, Italy; Department of Internal Medicine and Medical Specialities, School of Medicine, University of Genoa, Genoa, Italy., Giuliano M; Department of Clinical Medicine and Surgery, University Federico II, Naples, Italy., Montemurro F; Breast Unit, Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy., Puglisi F; Department of Medicine, University of Udine, Udine, Italy; Department of Medical Oncology, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano, Italy., Guarneri V; Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy; Oncology 2 Unit, Istituto Oncologico Veneto - IOV IRCCS, Padova, Italy., De Laurentiis M; Department of Breast and Thoracic Oncology, Division of Breast Medical Oncology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Pascale, Naples, Italy., Scafuri L; Oncology Unit, Hospital 'Andrea Tortora', ASL Salerno, Pagani, Italy; Associazione O.R.A. ETS - Oncology Research Assistance, Salerno, Italy., Arpino G; Department of Clinical Medicine and Surgery, University Federico II, Naples, Italy. Electronic address: grazia.arpino@unina.it.

Publikováno v: Breast (Edinburgh, Scotland) [Breast] 2024 Jun; Vol. 75, pp. 103713. Date of Electronic Publication: 2024 Mar 09.

Time to progression is the main predictor of survival in patients with high-risk nonmuscle invasive bladder cancer: Results from a machine learning-based analysis of a large multi-institutional database.

Autor: Porreca A; Biostatistics Laboratory, Department of Medical, Oral and Biotechnological Sciences, 'G. d'Annunzio' University of Chieti, Chieti, Italy., Di Nicola M; Biostatistics Laboratory, Department of Medical, Oral and Biotechnological Sciences, 'G. d'Annunzio' University of Chieti, Chieti, Italy., Lucarelli G; Urology, Andrology and Kidney Transplantation Unit, Department of Emergency and Organ Transplantation, University of Bari, Bari, Italy., Dorin VM; Department of Cell and Molecular Biology, George Emil Palade University of Medicine, Pharmacy, Sciences and Technology from Târgu Mureș, Târgu Mureș, Romania., Soria F; Division of Urology, Department of Surgical Sciences, Torino School of Medicine, Torino, Italy., Terracciano D; Department of Translational Medical Sciences, University Federico II, Napoli, Italy., Mistretta FA; Department of Urology, IEO European Institute of Oncology, IRCCS, Milan, Italy., Luzzago S; Department of Urology, IEO European Institute of Oncology, IRCCS, Milan, Italy., Buonerba C; CRTR Rare Tumors Reference Center, AOU Federico II, Napoli, Italy., Cantiello F; Department of Urology, Magna Graecia University of Catanzaro, Catanzaro, Italy., Mari A; Unit of Oncologic Minimally-Invasive Urology and Andrology, Department of Urology, Careggi Hospital, University of Florence, Florence, Italy., Minervini A; Unit of Oncologic Minimally-Invasive Urology and Andrology, Department of Urology, Careggi Hospital, University of Florence, Florence, Italy., Veccia A; Department of Urology, University of Verona, Verona, Italy., Antonelli A; Department of Urology, University of Verona, Verona, Italy., Musi G; Department of Urology, IEO European Institute of Oncology, IRCCS, Milan, Italy., Hurle R; Department of Urology, Humanitas Clinical and Research Hospital, Rozzano, Milan, Italy., Busetto GM; Department of Urology, University of Foggia, Foggia, Italy., Del Giudice F; Department of Urology, La Sapienza University of Rome, Rome, Italy., Ferretti S; Urology Unit, Department of Medical, Oral and Biotechnological Sciences, 'SS. Annunziata' Hospital, 'G. d'Annunzio' University of Chieti, Chieti, Italy., Perdonà S; Uro-Gynecological Department, Istituto Nazionale per lo Studio e la Cura dei Tumori, Fondazione 'G. Pascale'-IRCCS, Naples, Italy., Prete PD; Scientific Directorate, Istituto Nazionale per lo Studio e la Cura dei Tumori, Fondazione 'G. Pascale'-IRCCS, Naples, Italy., Porreca A; Department of Robotic Urologic Surgery, Abano Terme Hospital, Abano Terme, Italy., Bove P; Division of Urology, Department of Experimental Medicine and Surgery, Tor Vergata University of Rome, Rome, Italy., Crisan N; Department of Urology, University of Medicine and Pharmacy Iuliu Haţieganu, Cluj-Napoca, Romania., Russo GI; Department of Urology, University of Catania, Catania, Italy., Damiano R; Department of Urology, Magna Graecia University of Catanzaro, Catanzaro, Italy., Amparore D; Division of Urology, Department of Oncology, School of Medicine, San Luigi Hospital, University of Turin, Orbassano, Turin, Italy., Porpiglia F; Division of Urology, Department of Oncology, School of Medicine, San Luigi Hospital, University of Turin, Orbassano, Turin, Italy., Autorino R; Department of Urology, Rush University Medical Center, Chicago, IL., Piccinelli M; Department of Urology, IEO European Institute of Oncology, IRCCS, Milan, Italy., Brescia A; Department of Urology, IEO European Institute of Oncology, IRCCS, Milan, Italy., Tătaru SO; I.O.S.U.D., George Emil Palade University of Medicine, Pharmacy, Sciences and Technology from Târgu Mureș, Târgu Mureș, Romania., Crocetto F; Department of Neurosciences, Science of Reproduction and Odontostomatology, University of Naples Federico II, 80131 Naples, Italy., Giudice AL; Department of Urology, University of Catania, Catania, Italy., de Cobelli O; Department of Urology, IEO European Institute of Oncology, IRCCS, Milan, Italy., Schips L; Urology Unit, Department of Medical, Oral and Biotechnological Sciences, 'SS. Annunziata' Hospital, 'G. d'Annunzio' University of Chieti, Chieti, Italy., Ferro M; Department of Urology, IEO European Institute of Oncology, IRCCS, Milan, Italy., Marchioni M; Urology Unit, Department of Medical, Oral and Biotechnological Sciences, 'SS. Annunziata' Hospital, 'G. d'Annunzio' University of Chieti, Chieti, Italy. Electronic address: mic.marchioni@gmail.com.

Publikováno v: Urologic oncology [Urol Oncol] 2024 Mar; Vol. 42 (3), pp. 69.e17-69.e25. Date of Electronic Publication: 2024 Feb 01.